XML 62 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:    
Net loss $ (4,764) $ (3,115)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation and amortization 380 459
Amortization of debt discount and deferred financing costs 44 64
Loss on extinguishment of debt 67  
Stock-based employee compensation 819 461
Warrants issued with demand notes 436  
Restricted stock expense   2
Series C Preferred issued in settlement of indemnity claim   417
Common Stock received as settlement of 16b claim   (325)
(Gain) loss on derivative liability (103) (211)
Changes in operating assets and liabilities:    
Accounts receivable, net 291 (403)
Prepaid expenses and other assets 16 (44)
Accounts payable 252 (188)
Accrued Compensation 26 68
Other accrued liabilities 54 (93)
Deferred revenue (254) (96)
Net cash used in operating activities (2,736) (3,004)
Cash flows from investing activities:    
Acquisition of property and equipment (5) (12)
Net cash used in investing activities (5) (12)
Cash flows from financing activities:    
Net proceeds from issuance of short-term debt 1,460 2,328
Proceeds from exercise of warrants for cash 29 212
Proceeds from exercise of stock options   13
Principal payments on short term notes payable (310) (325)
Net cash provided by financing activities 3,199 3,195
Effect of exchange rate changes on cash and cash equivalents      
Net decrease in cash and cash equivalents 459 179
Cash and cash equivalents at beginning of period 486 307
Cash and cash equivalents at end of period 945 486
Supplemental disclosure of cash flow information:    
Interest paid 1 21
Income tax paid     
Non-cash financing and investing transactions:    
Cashless exercise of warrants 23 202
Dividends on preferred shares 2,088 1,465
Debt discount recorded in connection with short-term debt 111 64
Conversion of short-term notes plus accrued interest into Series D-1 Preferred shares 786 1,034
Conversion of short-term notes plus accrued interest into Series D-2 Preferred shares 393 2,065
Accretion of beneficial conversion feature related to dividends 250 666
Warrants issued in connection with the Series D financing    
Subscription Agreements 453  
Debt Conversion 587  
Exchange of May Series D financing 575  
Series B Preferred Stock [Member]
   
Non-cash financing and investing transactions:    
Dividends on preferred shares 1,044 948
Conversion of Preferred Stock into Common Stock    140
Accretion of beneficial conversion feature related to dividends    268
Series C Preferred Stock [Member]
   
Adjustments to reconcile net loss to net cash used for operating activities:    
Series C Preferred issued in settlement of indemnity claim   417
Non-cash financing and investing transactions:    
Dividends on preferred shares 433 389
Conversion of Preferred Stock into Common Stock 56 39
Accretion of beneficial conversion feature on Preferred Shares   417
Accretion of beneficial conversion feature related to dividends 191 385
Series D One Preferred Stock [Member]
   
Cash flows from financing activities:    
Proceeds from issuance of Preferred shares 810   
Non-cash financing and investing transactions:    
Dividends on preferred shares 131 14
Conversion of short-term notes plus accrued interest into Series D-1 Preferred shares 786 1,034
Accretion of beneficial conversion feature on Preferred Shares 929 1,110
Accretion of beneficial conversion feature related to dividends 59 13
Series D Two Preferred Stock [Member]
   
Cash flows from financing activities:    
Proceeds from issuance of Preferred shares 1,210 967
Non-cash financing and investing transactions:    
Dividends on preferred shares 402 41
Conversion of short-term notes plus accrued interest into Series D-2 Preferred shares 393 2,065
Accretion of beneficial conversion feature on Preferred Shares 68  
Accretion of beneficial conversion feature related to dividends